CD80 and B-cell non-Hodgkin lymphoma: Some researchers have found that the IL-4/anti-CD40 stromal cell culture system can induce high expression of CD80 in low-grade B-cell lymphoma under in vitro culture conditions, indicating that it is a potential immunotherapeutic target (37).